Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Immunomedics Inc announces orphan drug designation for IMMU-132 for Pancreatic Cancer Therapy
Immunomedics Inc announces orphan drug designation for IMMU-132 for Pancreatic Cancer Therapy
Immunomedics Inc announces orphan drug designation for IMMU-132 for Pancreatic Cancer Therapy
Submitted by
admin
on June 9, 2014 - 9:21am
Source:
Reuters
News Tags:
IMMU-132
orphan drugs
Immunomedics
pancreatic cancer
Headline:
Immunomedics Inc announces orphan drug designation for IMMU-132 for Pancreatic Cancer Therapy
Do Not Allow Advertisers to Use My Personal information
